Elm Street Ventures

About The Fund

Elm Street Ventures is a venture capital firm with a strong focus on fostering innovation within and around Yale University, investing primarily in companies with a Yale connection or located in the greater New Haven area. They have a preference for technologies developed at and licensed from Yale, but also consider exceptional cases outside this geographic and institutional focus, provided there is a strong, personal connection with founders or investors, or if they can add substantial value. Since its inception in 2006, Elm Street Ventures has concentrated on seed and early-stage investments in a wide range of sectors, including life science, therapeutic, laboratory tools, diagnostic, medical device, green technology, software, healthcare, mobile, healthcare service, clean technology, material science, sustainable technology, and information technology. Their investment thesis hinges on the belief that the combination of great people and great science leads to significant impact, therefore they heavily prioritize the strength and creativity of founding teams. They have also co-founded a number of their portfolio companies, recognizing the value and challenge of being involved from the earliest stages. The firm typically commits initial investments of $500,000 to $1 million and is prepared to follow-up with additional funding of $2 to $2.5 million in successful ventures across multiple financing rounds. Elm Street Ventures values the opportunity to work collaboratively, often syndicating with other investors who share their investment philosophy. The firm delineates their work by emphasizing their long-term commitment to building businesses which requires both time and hard work. Elm Street Ventures also showcases several specific portfolio companies on their website, like Arvinas, P2 Science, Allyx, Halda, and Cybrexa, which exemplify their focus on groundbreaking scientific research and potential for high impact solutions to global challenges.